Amedeo Smart

Free Medical Literature Service

 

Amedeo

Venous Thrombosis
  Free Subscription

Articles published in
Circulation
    March 2024
  1. AGGARWAL V, Giri J, Visovatti SH, Mahmud E, et al
    Status and Future Directions for Balloon Pulmonary Angioplasty in Chronic Thromboembolic Pulmonary Disease With and Without Pulmonary Hypertension: A Scientific Statement From the American Heart Association.
    Circulation. 2024 Mar 7. doi: 10.1161/CIR.0000000000001197.
    >> Share

    December 2023
  2. OSTERGAARD L, Olesen JB, Petersen JK, Nielsen LS, et al
    Arterial Thromboembolism in Patients With Atrial Fibrillation and CHA(2)DS(2)-VASc 1: A Nationwide Study.
    Circulation. 2023 Dec 28. doi: 10.1161/CIRCULATIONAHA.123.066477.
    >> Share

    November 2023
  3. GOTO S, Goto S
    Clinical Course of Isolated Distal Venous Thromboembolism in Patients With Active Cancer in a Nation With an Overall Low Risk of Thrombosis.
    Circulation. 2023;148:1677-1679.
    >> Share

  4. HOSOKAWA K, Watanabe H, Taniguchi Y, Ikeda N, et al
    A Multicenter, Single-Blind, Randomized, Warfarin-Controlled Trial of Edoxaban in Patients With Chronic Thromboembolic Pulmonary Hypertension: KABUKI Trial.
    Circulation. 2023 Nov 13. doi: 10.1161/CIRCULATIONAHA.123.067528.
    >> Share

    March 2023
  5. LASSEN MCH, Modin D, Skaarup KG, Johansen ND, et al
    Risk of Incident Thromboembolic and Ischemic Events After COVID-19 Vaccination Compared With SARS-CoV-2 Infection.
    Circulation. 2023;147:843-845.
    >> Share

    January 2023
  6. GOLDBERG JB, Giri J, Kobayashi T, Ruel M, et al
    Surgical Management and Mechanical Circulatory Support in High-Risk Pulmonary Embolisms: Historical Context, Current Status, and Future Directions: A Scientific Statement From the American Heart Association.
    Circulation. 2023 Jan 23. doi: 10.1161/CIR.0000000000001117.
    >> Share

    September 2022
  7. THIBORD F, Klarin D, Brody JA, Chen MH, et al
    Cross-Ancestry Investigation of Venous Thromboembolism Genomic Predictors.
    Circulation. 2022 Sep 26:101161CIRCULATIONAHA122059675.
    >> Share

    June 2022
  8. POGOSOVA N, Bosch J, Bhatt DL, Fox KAA, et al
    Rivaroxaban 2.5 mg Twice Daily Plus Aspirin Reduces Venous Thromboembolism in Patients With Chronic Atherosclerosis.
    Circulation. 2022;145:1875-1877.
    >> Share

    April 2022
  9. PARK DW, Ahn JM, Kang DY, Kim KW, et al
    Edoxaban versus Dual Antiplatelet Therapy for Leaflet Thrombosis and Cerebral Thromboembolism after TAVR: The ADAPT-TAVR Randomized Clinical Trial.
    Circulation. 2022 Apr 4. doi: 10.1161/CIRCULATIONAHA.122.059512.
    >> Share

    March 2022
  10. STEVENS H, Canovas R, Tran H, Peter K, et al
    Inherited Thrombophilias Are Associated With a Higher Risk of COVID-19-Associated Venous Thromboembolism: A Prospective Population-Based Cohort Study.
    Circulation. 2022;145:940-942.
    >> Share

    November 2021
  11. NAEIJE R
    Letter by Naeije Regarding Article, "Oxygen Pathway Limitations in Patients With Chronic Thromboembolic Pulmonary Hypertension".
    Circulation. 2021;144:e328-e329.
    >> Share

  12. HOWDEN EJ, Ruiz-Carmona S, La Gerche A, Delcroix M, et al
    Response by Howden et al to Letter Regarding Article, "Oxygen Pathway Limitations in Patients With Chronic Thromboembolic Pulmonary Hypertension".
    Circulation. 2021;144:e330-e331.
    >> Share

    August 2021
  13. AN ZY, Peng D, Shi YJ
    A Patient With Acute Shortness of Breath and Inferior ST-Segment Elevation: A Diagnostic Trap.
    Circulation. 2021;144:577-579.
    >> Share

    May 2021
  14. ROBERT-EBADI H, Robin P, Hugli O, Verschuren F, et al
    Impact of the Age-Adjusted D-Dimer Cutoff to Exclude Pulmonary Embolism: A Multinational Prospective Real-Life Study (the RELAX-PE Study).
    Circulation. 2021;143:1828-1830.
    >> Share

    April 2021
  15. HOWDEN EJ, Ruiz-Carmona S, Claeys M, de Bosscher R, et al
    Oxygen Pathway Limitations in Patients with Chronic Thromboembolic Pulmonary Hypertension.
    Circulation. 2021 Apr 15. doi: 10.1161/CIRCULATIONAHA.120.052899.
    >> Share

    March 2021
  16. BUKHARI S, Barakat AF, Eisele YS, Nieves R, et al
    Prevalence of Atrial Fibrillation and Thromboembolic Risk in Wild-Type Transthyretin Amyloid Cardiomyopathy.
    Circulation. 2021;143:1335-1337.
    >> Share

    February 2021

  17. Correction to: Call to Action to Prevent Venous Thromboembolism in Hospitalized Patients: A Policy Statement From the American Heart Association.
    Circulation. 2021;143:e249.
    >> Share

    November 2020
  18. PACKARD CJ
    Letter by Packard Regarding Article, "Peripheral Artery Disease and Venous Thromboembolic Events After Acute Coronary Syndrome: Role of Lipoprotein(a) and Modification by Alirocumab: Prespecified Analysis of the ODYSSEY OUTCOMES Randomized Clinical Tr
    Circulation. 2020;142:e333-e334.
    >> Share

  19. SCHWARTZ GG, Szarek M, Bittner VA, Steg PG, et al
    Response by Schwartz et al to Letter Regarding Article, "Peripheral Artery Disease and Venous Thromboembolic Events After Acute Coronary Syndrome: Role of Lipoprotein(a) and Modification by Alirocumab: Prespecified Analysis of the ODYSSEY OUTCOMES Ran
    Circulation. 2020;142:e335-e336.
    >> Share

    October 2020
  20. MARSTON NA, Ruff CT, Sabatine MS
    Response by Marston et al to Letter Regarding Article, "The Effect of PCSK9 (Proprotein Convertase Subtilisin/Kexin Type 9) Inhibition on the Risk of Venous Thromboembolism".
    Circulation. 2020;142:e264.
    >> Share

  21. QI Z, Sun A, Ge J
    Letter by Qi et al Regarding Article, "The Effect of PCSK9 (Proprotein Convertase Subtilisin/Kexin Type 9) Inhibition on the Risk of Venous Thromboembolism".
    Circulation. 2020;142:e262-e263.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016